Opioid Prescriber Education Program

NYS mandated training program

Enduring online activity

4 contact hours

Two-part program has been updated in 2023 into one comprehensive new program.

Target Audience

Prescribers licensed to treat humans and who have a Drug Enforcement Administration (DEA) number and medical residents prescribing under a facility DEA number.

On this page:

Program Overview

As part of ongoing efforts to address the epidemic of opioid overdose deaths, New York State has established educational requirements in Public Health Law Article 33 §3309-a to raise healthcare provider awareness of the risks associated with prescribing and taking opioid pain medications.  This program fulfills the mandate by providing education about state and federal requirements for prescribing controlled substances; pain management; appropriate prescribing; managing acute pain; palliative medicine; prevention, screening and signs of addiction; responses to abuse and addiction; and end of life care. 

Additionally, this activity fulfills four out of eight hours of the Medication Access and Training Expansion (MATE) Act requirement for all DEA-registered practitioners to complete training on the treatment and management of patients with opioid or other substance use disorders.



  • List the Federal and New York State (NYS) requirements for prescribing controlled substances
  • Define the NYS Prescription Monitoring Program (PMP) and its purpose
  • Describe NYS 7-day rules

Pain Management:

  • Describe the pathophysiology and general approaches for pain assessment in the ambulatory setting
  • Describe approaches for managing acute pain and how they differ from approaches for managing chronic pain
  • Outline evidence-based best practices for appropriate prescribing of opioid analgesics

Opioid Use Disorder (OUD):

  • Identify risk factors for the development of OUD
  • Describe screening tools and processes that may be used to identify signs of OUD
  • Describe strategies to mitigate the risk of iatrogenic OUD
  • Discuss treatment approaches based on whether the patient has chronic pain, OUD, both, or neither
  • Explain harm reduction strategies

Palliative Care:

  • Outline principles of and differences between palliative care and hospice care
  • Describe the use of opioids in hospice and palliative care (e.g., cancer pain, dyspnea, methadone)

Program Components

This program contains a pre-test, video presentation, downloadable educational materials, post-test, and a program evaluation. Credit will be awarded upon successful completion of the post-test activity with a score of 70% or better. 

Prescribers, please be sure to attest once you have completed the course at



Karl Fiebelkorn.

Karl D. Fiebelkorn, BSPharm, RPh, MBA

Senior Associate Dean
UB School of Pharmacy and Pharmaceutical Sciences 

Dr. Romanth Waghmarae.

Romanth Waghmarae, MD, DABA, FACIP, FIPP

Assistant Clinical Professor - Anesthesia
McMaster University

Research Assistant Professor
UB School of Pharmacy and Pharmaceutical Sciences

Dr. Arthur Weissman.

Arthur Weissman, MD, FASAM

Assistant Professor
Department of Family Medicine
UB Jacobs School of Medicine and Biomedical Sciences

Robert Wahler.

Robert G. Wahler Jr., PharmD, CPE

Clinical Associate Professor
Department of Pharmacy Practice
UB School of Pharmacy and Pharmaceutical Sciences

Clinical Pharmacy Services, Niagara Hospice, Inc


There is no fee associated with this program.

Program Support

The program is supported by the Cooperative Agreement 6 NU17CE924974-03, funded by the Centers for Disease Control and Prevention and supported by the New York State Department of Health. The contents were developed in collaboration between the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and New York State Department of Health, and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Accreditation Information

Prescribers and Dentists will receive, via email, your certificate of attendance and letter of completion within 48 hours after successful completion of the activity. 

(Please check your spam or junk mail folder if you do not see it in your inbox.)

Accreditation Types:  ACCME, ADA/CERP, ACPE


The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

The University at Buffalo School Jacobs School of Medicine and Biomedical Sciences designates this Enduring Material activity for a maximum of 4.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The University at Buffalo, Continuing Dental Education is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

UB Continuing Dental Education designates this activity for 4 credit hours, ADA/CERP continuing education credit.



The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This continuing education program has been accredited as knowledge-based enduring activity. Credit will be uploaded to the CPE Monitor to those who successfully complete all components of the activity.

No partial credit is available

Opioid Prescriber Education Program, ACPE# 0044-0000-23-031-H08-P, 4 Contact Hrs., (0.400 ceus).


Release date:  7/14/2023

Expiration date: 7/13/2026

Recommended Browsers

Recommended Web Browsers:

How to Enable Cookies:

Please do not use Internet Explorer as your browser for this program.